Connection
Dale Terasaki to Naltrexone
This is a "connection" page, showing publications Dale Terasaki has written about Naltrexone.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.957 |
|
|
|
-
Deaney M, Terasaki D. Intramuscular, extended-release naltrexone inadvertently administered in the deltoid muscle: A case report. J Am Pharm Assoc (2003). 2023 Jul-Aug; 63(4):1245-1248.
Score: 0.788
-
Terasaki D. Self-reported Past Experiences With Naltrexone and Attitudes Toward Daily Adherence Among High-utilization Patients With Alcohol Use Disorder. J Addict Med. 2023 May-Jun 01; 17(3):371-372.
Score: 0.770
-
Terasaki D, Ellinwood A, White D. Quadruple pharmacotherapy for alcohol use disorder tolerable yet insufficient: a case report. Subst Abuse Treat Prev Policy. 2024 Feb 29; 19(1):18.
Score: 0.208
-
Terasaki D, Loh R, Cornell A, Taub J, Thurstone C. Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates. Addict Sci Clin Pract. 2022 11 22; 17(1):64.
Score: 0.190